Patents Assigned to Hemanext Inc.
  • Publication number: 20260144821
    Abstract: The present disclosure relates to methods for treating blood transfusion-dependent hematological malignancy patients with oxygen reduced blood.
    Type: Application
    Filed: October 20, 2023
    Publication date: May 28, 2026
    Applicant: Hemanext Inc.
    Inventors: Martin CANNON, Andrew DUNHAM, Laurel OMERT, Kimberly DORSCH, Michael DIOGUARDI
  • Publication number: 20260144822
    Abstract: The present disclosure relates to methods for treating burn patients with oxygen reduced blood.
    Type: Application
    Filed: October 20, 2023
    Publication date: May 28, 2026
    Applicant: Hemanext Inc.
    Inventors: Martin CANNON, Andrew DUNHAM, Laurel OMERT
  • Patent number: 12604890
    Abstract: The present disclosure relates to Oxygen Reduction Disposable kits (ORDKit), devices and methods for the improved preservation of whole blood and blood components. The improved devices and methods for the collection of blood and blood components provide for whole blood and blood components having reduced levels of oxygen. The devices and methods provide for the rapid preparation of deoxygenated blood and blood components for storage that improves the overall quality of the transfused blood and improves health outcomes in patients.
    Type: Grant
    Filed: April 7, 2023
    Date of Patent: April 21, 2026
    Assignee: Hemanext Inc.
    Inventors: Michael Wolf, Jancarlo Sarita, Jeffrey Karl Sutton, Rafael Cordero, Michael Zocchi, Philip Keegan, Narendran Renganathan, Robert Harhen
  • Patent number: 12582674
    Abstract: Methods for the reversal of hemorrhagic shock or hemorrhagic trauma. Methods for reducing levels of aspartate aminotransferase (AST) and alanine aminotransferase (ALT) in a trauma patient through the administration of stored oxygen reduced blood products.
    Type: Grant
    Filed: January 9, 2023
    Date of Patent: March 24, 2026
    Assignee: Hemanext Inc.
    Inventors: Andrew Dunham, Tatsuro Yoshida
  • Publication number: 20260041772
    Abstract: A method for reducing hemolysis and microparticle formation during storage of pathogen reduced blood. Oxygen reduced blood compositions comprising SAGM and riboflavin having reduced hemolysis. Oxygen reduced blood compositions comprising SAGM and riboflavin having reduced microparticles. Oxygen and pathogen reduced blood compositions comprising CPAD and riboflavin having reduced hemolysis. Oxygen and pathogen reduced blood compositions comprising SAGM and riboflavin having reduced microparticles.
    Type: Application
    Filed: June 20, 2025
    Publication date: February 12, 2026
    Applicant: Hemanext Inc.
    Inventors: Samuel O. SOWEMIMO-COKER, Jeffrey SUTTON, Tatsuro YOSHIDA
  • Patent number: 12502462
    Abstract: A system and methodology for the preservation of red blood cells is described in which red blood cells are oxygen or oxygen and carbon dioxide depleted, treated and are stored in an anaerobic environment to optimize preparation for transfusion. More particularly, a system and method for extended storage of red blood cells from collection to transfusion that optimizes red blood cells prior to transfusion is described.
    Type: Grant
    Filed: July 25, 2022
    Date of Patent: December 23, 2025
    Assignee: Hemanext Inc.
    Inventors: Tatsuro Yoshida, Paul Vernucci
  • Patent number: 12447177
    Abstract: Methods for prevention and reversal of inflammation.
    Type: Grant
    Filed: November 14, 2019
    Date of Patent: October 21, 2025
    Assignee: Hemanext Inc.
    Inventors: Andrew Dunham, Tatsuro Yoshida, Samuel O. Sowemimo-Coker
  • Publication number: 20250268792
    Abstract: A blood storage container for the anaerobic storage of blood, having enhanced scaling methods and materials for the preservation of stored blood is provided.
    Type: Application
    Filed: August 29, 2024
    Publication date: August 28, 2025
    Applicant: Hemanext Inc.
    Inventors: Tatsuro YOSHIDA, Rafael CORDERO, Jancarlo SARITA, Michael ZOCCHI, Michael WOLF, Philip Michael KEEGAN, Narendran RENGANATHAN, Jeffrey Karl SUTTON
  • Patent number: 12364760
    Abstract: A method for reducing hemolysis and microparticle formation during storage of pathogen reduced blood. Oxygen reduced blood compositions comprising SAGM and riboflavin having reduced hemolysis. Oxygen reduced blood compositions comprising SAGM and riboflavin having reduced microparticles. Oxygen and pathogen reduced blood compositions comprising CPAD and riboflavin having reduced hemolysis. Oxygen and pathogen reduced blood compositions comprising SAGM and riboflavin having reduced microparticles.
    Type: Grant
    Filed: January 19, 2024
    Date of Patent: July 22, 2025
    Assignee: Hemanext Inc.
    Inventors: Samuel O. Sowemimo-Coker, Jeffrey Sutton, Tatsuro Yoshida
  • Publication number: 20250177440
    Abstract: Method for transfusion medicine to reduce adverse events in transfusion patient populations based on underlying patient physiology.
    Type: Application
    Filed: February 13, 2025
    Publication date: June 5, 2025
    Applicant: Hemanext Inc.
    Inventors: Angelo D'ALESSANDRO, Rafael CORDERO, Andrew DUNHAM, Philip KEEGAN, Tatsuro YOSHIDA
  • Patent number: 12201584
    Abstract: A blood storage container for the anaerobic storage of blood, having enhanced sealing methods and materials for the preservation of stored blood is provided.
    Type: Grant
    Filed: October 16, 2020
    Date of Patent: January 21, 2025
    Assignee: Hemanext Inc.
    Inventors: Tatsuro Yoshida, Rafael Cordero, Jancarlo Sarita, Michael Zocchi, Michael Wolf, Philip Michael Keegan, Narendran Renganathan, Jeffrey Karl Sutton
  • Publication number: 20240423196
    Abstract: A blood storage system comprising: a collection vessel for red blood cells; an oxygen or oxygen and carbon dioxide depletion device; a storage vessel for red blood cells; tubing connecting the collection vessel to the oxygen or oxygen and carbon dioxide depletion device and the oxygen or oxygen and carbon dioxide depletion device to the storage vessel; and a gamma or X-ray irradiating device is used to irradiate red blood cells stored in the vessel, storing red blood cells under anaerobic conditions.
    Type: Application
    Filed: September 6, 2024
    Publication date: December 26, 2024
    Applicant: Hemanext Inc.
    Inventors: Tatsuro YOSHIDA, Paul VERNUCCI
  • Patent number: 12089589
    Abstract: A blood storage system comprising: a collection vessel for red blood cells; an oxygen or oxygen and carbon dioxide depletion device; a storage vessel for red blood cells; tubing connecting the collection vessel to the oxygen or oxygen and carbon dioxide depletion device and the oxygen or oxygen and carbon dioxide depletion device to the storage vessel; and a gamma or X-ray irradiating device is used to irradiate red blood cells stored in the vessel, storing red blood cells under anaerobic conditions.
    Type: Grant
    Filed: March 23, 2022
    Date of Patent: September 17, 2024
    Assignee: Hemanext Inc.
    Inventors: Tatsuro Yoshida, Paul Vernucci
  • Publication number: 20240156682
    Abstract: The present disclosure relates to improved collapsible blood containers comprising reinforced silicone for use in Oxygen Reduction Disposable kits (ORDKit), devices and methods. The improved collapsible blood containers and methods for the collection of blood and blood components provide for improved burst, tear, and puncture resistance.
    Type: Application
    Filed: August 18, 2023
    Publication date: May 16, 2024
    Applicant: Hemanext Inc.
    Inventors: Robert HARHEN, Peter PIGNONE, Narendran RENGANATHAN, Jancarlo SARITA, Jeffrey Karl SUTTON, Michael WOLF, Michael R. ZOCCHI
  • Publication number: 20240158751
    Abstract: The present disclosure relates to devices and methods for the improved storage and expansion of stem cells.
    Type: Application
    Filed: March 7, 2022
    Publication date: May 16, 2024
    Applicant: Hemanext Inc.
    Inventor: Samuel O. SOWEMIMO-COKER
  • Publication number: 20240148872
    Abstract: A method for reducing hemolysis and microparticle formation during storage of pathogen reduced blood. Oxygen reduced blood compositions comprising SAGM and riboflavin having reduced hemolysis. Oxygen reduced blood compositions comprising SAGM and riboflavin having reduced microparticles. Oxygen and pathogen reduced blood compositions comprising CPAD and riboflavin having reduced hemolysis. Oxygen and pathogen reduced blood compositions comprising SAGM and riboflavin having reduced microparticles.
    Type: Application
    Filed: January 19, 2024
    Publication date: May 9, 2024
    Applicant: Hemanext Inc.
    Inventors: Samuel O. SOWEMIMO-COKER, Jeffrey SUTTON, Tatsuro YOSHIDA
  • Patent number: 11911471
    Abstract: A method for reducing hemolysis and microparticle formation during storage of pathogen reduced blood. Oxygen reduced blood compositions comprising SAGM and riboflavin having reduced hemolysis. Oxygen reduced blood compositions comprising SAGM and riboflavin having reduced microparticles. Oxygen and pathogen reduced blood compositions comprising CPAD and riboflavin having reduced hemolysis. Oxygen and pathogen reduced blood compositions comprising SAGM and riboflavin having reduced microparticles.
    Type: Grant
    Filed: September 23, 2021
    Date of Patent: February 27, 2024
    Assignee: Hemanext Inc.
    Inventors: Samuel O. Sowemimo-Coker, Jeffrey Sutton, Tatsuro Yoshida
  • Publication number: 20230247984
    Abstract: The present disclosure relates to Oxygen Reduction Disposable kits (ORDKit), devices and methods for the improved preservation of whole blood and blood components. The improved devices and methods for the collection of blood and blood components provide for whole blood and blood components having reduced levels of oxygen. The devices and methods provide for the rapid preparation of deoxygenated blood and blood components for storage that improves the overall quality of the transfused blood and improves health outcomes in patients.
    Type: Application
    Filed: April 7, 2023
    Publication date: August 10, 2023
    Applicant: Hemanext Inc.
    Inventors: Michael WOLF, Jancarlo SARITA, Jeffrey Karl SUTTON, Rafael CORDERO, Michael ZOCCHI, Philip KEEGAN, Narendran RENGANATHAN, Robert HARHEN
  • Patent number: D1084308
    Type: Grant
    Filed: December 9, 2022
    Date of Patent: July 15, 2025
    Assignee: Hemanext Inc.
    Inventors: Ayan Bhandari, David Copeland, Rafael Cordero, Jancarlo Sarita, Jeffrey Sutton, Michael Zocchi
  • Patent number: D1084309
    Type: Grant
    Filed: December 9, 2022
    Date of Patent: July 15, 2025
    Assignee: Hemanext Inc.
    Inventors: Ayan Bhandari, David Copeland, Rafael Cordero, Jancarlo Sarita, Jeffrey Sutton, Michael Zocchi